Kevin P. Starr is Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have made 14 open-market trades across 9 companies since 2013, most recently 2021-11-10.
CIK 0001192603
2 open-market purchases totalling $3.3M since 2019, against 12 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 60% | 30% |
| Avg Move | +1.3% | -1.8% | +16.2% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SAGE | BUY | 2021-06-16 | 2021-06-17 | $56.05 | $2.0M | +1.2% | -17.0% | -19.3% |
| JNCE | SELL | 2021-03-01 | 2021-03-03 | $11.75 | $17.0M | -1.5% | -10.9% | -33.9% |
| FULC | BUY | 2019-07-22 | 2019-07-22 | $16.00 | $1.3M | +14.0% | -12.1% | -65.5% |
| SAGE | SELL | 2018-04-17 | 2018-04-19 | $168.86 | $10.0M | -12.3% | -3.2% | -0.3% |
| MYOK | SELL | 2018-01-03 | 2018-01-05 | $42.00 | $34.3M | +25.7% | +18.2% | +9.1% |
| MYOK | SELL | 2017-10-03 | 2017-10-04 | $40.28 | $6.1M | -7.8% | +2.4% | +4.2% |
| MYOK | SELL | 2017-09-25 | 2017-09-27 | $43.00 | $25.9M | -1.4% | -8.9% | +3.7% |
| MYOK | SELL | 2017-09-08 | 2017-09-12 | $41.01 | $8.3M | +3.6% | -8.1% | -9.6% |
| CTMX | SELL | 2017-04-12 | 2017-04-14 | $16.36 | $928K | +5.5% | -3.8% | +2.2% |
| BPMC | SELL | 2016-12-19 | 2016-12-21 | $28.19 | $6.0M | +5.0% | +13.8% | +43.9% |
| GBT | SELL | 2016-12-16 | 2016-12-20 | $16.00 | $1.7M | -12.3% | +2.1% | +129.1% |
| EDIT | SELL | 2016-09-06 | 2016-09-07 | $15.90 | $94K | -10.3% | -14.5% | -2.9% |
| SAGE | SELL | 2016-05-16 | 2016-05-18 | $31.25 | $26.6M | +6.1% | -8.7% | +15.5% |
| ALNY | SELL · 10b5-1 | 2015-11-11 | 2015-11-13 | $103.89 | $7.8M | -18.4% | +0.9% | -38.2% |
| ZFGN | SELL | 2015-09-24 | 2015-09-25 | $43.90 | $6.0M | -0.3% | +1.3% | +1.3% |
| ALNY | SELL · 10b5-1 | 2014-09-24 | 2014-09-26 | $78.09 | $7.0M | -18.4% | +0.9% | +0.9% |
| ALNY | SELL · 10b5-1 | 2013-03-25 | 2013-03-26 | $23.49 | $1.2M | -18.4% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| 184,386 |
| $5.8M |
| GBT | 82,544 | $5.7M |
| SAGE | 320,659 | $2.8M |
| ZFGN | 210,371 | $2.5M |
| ALNY | 900 | $209K |
| HGSI | 695 | — |
| Total | $381.5M |
Shares reported on the most recent Form 4, priced at the 2021-11-12 close. 1 holding could not be priced and is excluded from the total.